As the precision medicine field accelerates toward transformative breakthroughs, it’s imperative to share the voices shaping its trajectory. The inaugural Women of Precision Medicine: 25 Perspectives for 2025 collection captures forward-thinking insights from leaders who are not only advancing healthcare innovation but also breaking barriers for equitable care.
What is Women of Precision Medicine?
The Women of Precision Medicine (WOPM) initiative was created to amplify women’s leadership in this rapidly evolving field. Our mission is to celebrate the groundbreaking work of women innovators and inspire future generations to pursue impactful careers in precision medicine. Through thought leadership pieces like this one, we aim to showcase their diverse contributions, from driving cutting-edge research to reshaping patient care.
Who Participated in This Year’s WOPM?
This year’s perspectives were drawn from leaders across women’s health, early cancer detection, digital pathology, artificial intelligence, and more. Nominations for contributors came from across the industry, and our team carefully curated this list of 25 innovators, highlighting individuals who are pushing boundaries and addressing the field's most pressing challenges. A special thank you to all the women who contributed their insights, time, and expertise to this initiative.
Key Themes from This Year’s WOPM Perspectives
- Making Diagnostics Accessible to All
Leaders like Susan Tousi, CEO of Delfi Diagnostics, emphasize the need for affordable, point-of-care diagnostic solutions. Such innovations can bring cancer screening to the masses, potentially saving countless lives through early detection. - Harnessing AI for Transformative Healthcare
Artificial intelligence is revolutionizing life sciences. Kate Sasser, Ph.D., of Tempus AI, envisions 2025 as the year AI-enabled precision medicine goes mainstream, aiding drug discovery and personalized clinical decisions. Similarly, Alicia Zhou, Ph.D., highlights the need for robust, diverse datasets to truly unlock AI’s potential in equitable precision medicine. - Women’s Health: A Crucial Frontier
From hormonal health to pregnancy complications, women’s health remains an underserved yet promising area. Leaders like Carrie Haverty of Mirvie are championing new investments in women’s cardiovascular and pregnancy-related health, while Amy Sharma of BillionToOne stresses the need for stronger partnerships between diagnostics and therapeutics. - Multi-Omics and Cross-Disciplinary Collaboration
The integration of genomics, proteomics, and metabolomics is redefining diagnostics and treatment strategies. Oriana Papin-Zoghbi of AOA Dx and Dawn Mattoon, Ph.D., of Mercy BioAnalytics, highlight multi-omic innovations that can transform early cancer detection and patient outcomes. - Equity and Diversity in Data and Care
The industry must address disparities in access to testing and treatment. Michelle Teng, Ph.D., underscores the ethical and scientific imperative of embracing diversity in genomic research. As she aptly notes, diversity isn’t just about fairness; it’s a cornerstone for innovation. - The AI and Proteomics Revolution
Amanda Cashin, Ph.D., predicts 2025 as the "year of proteomics," with technologies advancing our understanding of biology's functional drivers. Meanwhile, others foresee AI enabling clinicians to bridge gaps in precision diagnostics and therapy optimization. - Collaboration as the Key to Progress
Many contributors stress the importance of partnerships across sectors. Jill Stefanelli of Modella AI and Meredith Reichert, Ph.D., of Karius, advocate for breaking silos to tackle the biggest challenges in precision medicine, from antimicrobial resistance to expanding cancer screening.
Looking Ahead
The perspectives shared in this compendium reaffirm that precision medicine’s promise is immense but requires a collective, equitable effort to achieve its full potential. As we step into 2025, let these insights from industry leaders inspire continued innovation, collaboration, and dedication to improving patient outcomes.
Do you know a leader or future leader making an impact in precision medicine? We’d love to hear from you. Nominate them by filling out this form to be part of future Women of Precision Medicine initiatives and help us continue amplifying the women shaping this field.
Comments and opinions expressed by interviewees are their own and do not represent or reflect the opinions, policies, or positions of DeciBio Consulting or have its endorsement. Note: DeciBio Consulting, its employees or owners, or our guests may hold assets discussed in this article/episode. This article/blog/episode does not provide investment advice, and is intended for informational and entertainment purposes only. You should do your own research and make your own independent decisions when considering any financial transactions.